Dissolution Technologies

Papers
(The median citation count of Dissolution Technologies is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Study of Drug Release Kinetics of Rosuvastatin Calcium Immediate-Release Tablets Marketed in Saudi Arabia7
Update on Gastrointestinal Biorelevant Media and Physiologically Relevant Dissolution Conditions5
Testing the In-Vitro Product Performance of Nanomaterial-Based Drug Products: View of the USP Expert Panel5
Stimuli to the Revision Process: The Case for Apex Vessels5
Comparative Dissolution of Budesonide from Four Commercially Available Products for Oral Administration: Implications for Interchangeablity4
In Vitro Biopharmaceutical Equivalence of Carbamazepine Sodium Tablets Available in Lima, Peru4
Simulated Lymphatic Fluid for In-Vitro Assessment in Pharmaceutical Development4
Development of In Vivo Predictive pH-Gradient Biphasic Dissolution Test for Weakly Basic Drugs: Optimization by Orthogonal Design3
Comparative Evaluation of In Vitro Drug Release Methods Employed for Nanoparticle Drug Release Studies3
In Vitro Solubility and Release Profile Correlation with pKa Value of Efavirenz Polymorphs3
Disintegration and Rupture Testing of Omega-3 Soft Capsules3
Effect of Mannitol Particle Size on Melatonin Dissolution and Tablet Properties using a Quality by Design Framework3
Predicting Dissolution of Entecavir Using the Noyes Whitney Equation2
Quality Assessment of Brands of Prednisolone (5 Mg) Tablets Marketed in Abuja Metropolis of Nigeria2
Evaluation of NanoDis as an Automated Sampling Technology for In Vitro Release Testing of Nanomedicines2
Dissolution Method Development for Regulatory Approval: A Comprehensive Review and Case Study2
Predictive Dissolution Models for Real-Time Release Testing: Development and Implementation - Workshop Summary Report2
A Data Set to Verify Volume and Sample Removal Correction Calculations for Dissolution Testing2
In-Vitro Product Performance of Parenteral Drug Products: View of the USP Expert Panel2
In Vitro Biopharmaceutical Equivalence of 5-mg Glibenclamide Tabletsin Simulated Intestinal Fluid Without Enzymes2
Conventional Surfactants and a Model Based on Molecular Descriptors as Alternatives to the Drug Solubility in Fasted State Simulated Intestinal Fluid1
Comparison of Generic Furosemide Products by In Vitro Release Studies using USP Apparatus 2 and 41
Comparative Assessment of Critical Quality Attributes of Sildenafil Tablets1
Biorelevant Dissolution Testing of Numerically Optimized Multiparticulate Drug Delivery Systems of Gliclazide1
Overview of the Activities of the USP Expert Panel on New Advancements in Product Performance Testing1
Biowaiver Study of Selected Solid Oral Prednisolone Products Available in Sri Lanka: Recommendations for Comparator Product Used in Biowaiver Testing1
Summary Report on Workshop on In Vitro Release Test (IVRT) and In Vitro Permeation Test (IVPT) Methods1
A Novel Application of an Effervescent Agent in Naproxen Liqui-Pellets for Enhanced Drug Release1
The Combination of Liqui-Mass System and Pelletization to Improve Pharmaceutical Properties of Hydrochlorothiazide1
In-Vitro Product Performance of Parenteral Drug Products: View of the USP Expert Panel1
Quality Attributes and In Vitro Bioequivalence of Amlodipine (5 mg) Tablets in Ica, Peru1
Performance Tests – Update on USP Activities1
Development of In Vitro Dissolution Test Method for Bilastine and Montelukast Fixed-Dose Combination Tablets1
Highlights from the 2020 AAPS 360 Annual Meeting1
Advances in Product Quality and Performance Tests for Topical and Transdermal Products: View of the USP Expert Panel1
Dissolution Profile of Apixaban Tablets: Method Development and Validation Using HPLC Analysis1
Dissolution Method Troubleshooting: An Industry Perspective1
Questions and Answers February 20211
Role of Surfactants on Dissolution Behavior of Tamoxifen1
A BCS-Based Biowaiver Approach Using Biphasic Dissolution Test1
Dissolution Best Practices and International Harmonization - AAPS Workshop Report1
Highlights from the 2023 AAPS 360 Annual Meeting - In Vitro Release and Dissolution0
Questions and Answers November 20220
Assessment of Drug Release Kinetics and Quality of Naproxen Generic Tablets in Bangladesh0
Life Cycle Application of AQbD for Formulation Development and Validation of a Dissolution Method for Nevirapine0
Release Profile of Branded Atorvastatin Calcium Tablet Relative to Commercially Available Counterpart Generics0
Comparative Study of Metformin Hydrochloride Tablets in Argentina0
Contribution of Multivariate Analysis to the In Vitro Dissolution Profile for Testing Clopidogrel Drugs Similarity0
Evaluation of Critical Quality Attributes of Dapsone Gel0
Application of Salicylic Acid Tablets in the Performance Verification Test for the Flow-Through Cell Apparatus0
Comparative Evaluation of Amlodipine Besylate Generic Tablet and Capsule Brands in Riyadh, Saudi Arabia0
The Importance of Dissolution Tests to Evaluate Quality of Dietary Supplements: Case Study of Controlled Release Caffeine Capsules0
Influence of Different Concentrations of Surfactants on Dissolution Profiles of Extemporaneously Compounded Pessaries with Clindamycin Phosphate0
Virtual Workshop Report: Approaches, Regulatory Challenges, and Advances in Bioequivalence, Dissolution Testing, and Biowaivers: Manila, Philippines, February 22-24, 20230
An In Vitro Model for Release of Acetaminophen When an Overdose is Ingested Orally0
Questions and Answers August 20230
Dissolution Profile of Calcium Supplements in Brazil: A Critical Analysis and Formulation Proposal0
Questions and Answers May 20240
Book Review: “Analytical Testing for the Pharmaceutical GMP Laboratory”0
Questions and Answers May 20210
Influence of Storage Conditions on the Pantoprazole Dissolution Profile for Gastro-Resistant Tablet Formulations0
In Vitro Bioequivalence of Acetylsalicylic Acid and Implications in Public Health0
Comparative Study of Metformin Hydrochloride Tablets in Argentina0
Questions and Answers November 20230
Quality Control Parameters of Antihypertensive Medications Marketed in Eastern Ethiopia: Amlodipine Besylate and Enalapril Maleate Tablets0
Questions and Answers February 20240
Physicochemical Quality and In Vitro Bioequivalence of Amoxicillin Capsules Marketed in Burkina Faso, Africa0
Pharmaceutical Equivalence of Losartan Potassium Tablets in Argentina0
Highlights from 2022 AAPS 360-In Vitro Release and Dissolution Testing Community Annual Meeting0
Evaluation of a pH-Gradient Biphasic Dissolution Test for Predicting In Vivo Performance of Weakly Basic Drugs0
Comparison of In Vitro Phosphate-Binding Studies of Sevelamer Carbonate Using Incubator Shaker and USP Dissolution Apparatus II0
Comparative Analysis of Commercially Available Acetaminophen Tablets in Saudi Arabia0
Comparative Dissolution Study of Enzalutamide Capsules in India0
In Vitro Performance Tests for Continuous Manufacturing: The Impact on the Current Compendial Framework from the Viewpoint of the USP New Advancements in Product Performance Testing Expert Panel0
Impact of Vessel Inner Diameter in USP Dissolution Apparatus 20
Preparation and Characterization of a Novel Optimum Modified Liquisolid Compact to Enhance the Dissolution Profile of Mifepristone0
Comparative Study of Brand and Generics Ciprofloxacin Tablets Available in the Saudi Market0
Book Review: “In Vitro Drug Release Testing of Special Dosage Forms,” Advances in Pharmaceutical Technology Series, Edited by Fotaki and Klein0
Formulation and Evaluation of Bisoprolol Hemifumarate Emulgel for Transdermal Drug Delivery0
Investigating the Influence of HPMC K4M and Eudragit L 100-55 on Guanfacine-Loaded Extended-Release Tablets0
Biorelevant Dissolution of Dipyridamole and Piroxicam Using an Automated UV/Vis Spectrophotometric and Potentiometric Dissolution Testing Platform0
Dissolution Specifications for Ibuprofen Soft Gelatin Capsules: A Proposal0
Comparison of Efavirenz Release in Biorelevant Dissolution Media Using Manual Sampling and In Situ UV Fiber Optic System0
Selection and Parameters Affecting Dissolution Media0
Review: Application of Bioequivalence Testing of Medicines in Peru0
Questions and Answers August 20210
Evaluation of In Vitro Equivalence of Commonly Available Generic Brands of Amlodipine Tablets in Saudi Arabia Under Biowaiver Conditions0
Therapeutic Equivalence Evaluated Through In Vitro Studies of Multi-Source Drugs: A Moxifloxacin Case Study in Lima, Peru0
Magnesium Stearate - Its Importance and Potential Impact on Dissolution of Oral Solid Dosage Forms0
Comparison of Rosuvastatin Calcium Tablets Marketed in Saudi Arabia Under Biowaiver Conditions: In Vitro Quality Control Dissolution Study0
New USP Dissolution Performance Verification Standard: What, Where, and When0
Report on the Virtual Workshop: A Quest for Biowaiver, Including Next Generation Dissolution Characterization and Modeling0
Questions and Answers May 20230
Preparation and Characterization of ZGDHu-1 Nanoparticles0
Comparative Dissolution Study of Various Brands of Valsartan Tablets Marketed in Pakistan0
Evaluation of Different Methods for Dissolution Profile Similarity Comparison of Montelukast Tablets in Türkiye0
Questions and Answers August 20220
Questions and Answers November 20210
Dissolution Testing Strategies for Large Sample Sizes and Applications in Continuous Manufacturing0
Improved Melatonin Dissolution Properties: A Way Forward for Treating Children with Sleep Disorders0
Factors Influencing the Selection of Medium for Evaluating Drug Solubility and Dissolution in Bovine Milk0
Dissolution Test of Patent and Generic Drugs of Metformin Hydrochloride0
Testing the In Vitro Product Performance of Mucosal Drug Products: View of the USP Expert Panel0
Using a Laser Monitoring Technique for Dissolution and Thermodynamic Study of Celecoxib in 2-Propanol and Propylene Glycol Mixtures0
Therapeutic Equivalence of Multisource Drugs Assessed by In Vitro Dissolution Studies: Amoxicillin/Clavulanic Acid Tablets0
In Vitro Product Performance Testing of Oral Drug Products: View of the USP Expert Panel0
Questions and Answers February 20230
Dissolution Performance of Verapamil-HCl Tablets Using USP Apparatus 2 and 4: Prediction of In Vivo Plasma Profiles0
Highlights From the 2021 AAPS 360 Annual Meeting0
Comparison of Release Rates Derived from Cutaneous Versus Film-Forming Solution Containing Terbinafine: Approach Towards Qualification and Validation of In Vitro Parameters0
Influence of Storage Conditions on Pharmaceutical Equivalence and Similarity of Hydrochlorothiazide Tablets in Argentina0
Impact of Solvent Selection and Absorptivity on Dissolution Testing of Acetylsalicylic Acid Enteric-Coated Tablets0
Questions and Answers February 20220
Questions and Answers August 20240
In Vitro Characterization of Multi-Source Omeprazole Capsule Dissolution Performance Under Biorelevant Conditions0
Comparative Dissolution Study of Atorvastatin Calcium Tabletsin Indonesia0
0.03381609916687